Basic Information
One2Treat is committed to transforming the way biopharmaceutical companies design, analyze, and interpret randomized clinical trials, as well as how they communicate the overall medical value of treatments. Through its innovative software platform and patient-centered approach, One2Treat helps sponsors incorporate the patient voice into early trial design, endpoint selection, and therapeutic value assessment. By aligning clinical evidence generation with the needs of patients and clinicians, One2Treat supports more meaningful clinical trials, efficient decision-making, and enhanced regulatory discussions, thereby accelerating market access. One2Treat's mission is to develop methodologies and advanced software that enable a holistic evaluation of treatment effects by integrating all key patient-relevant outcomes into a single comprehensive assessment of net treatment benefit.